Bleeding Disorder News and Research

RSS
Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer receives FDA approval for lower dose formulation of ANGELIQ

FDA grants orphan drug designation to CSL Behring's rVIIa-FP

FDA grants orphan drug designation to CSL Behring's rVIIa-FP

CSL Behring announces results of rIX-FP Phase I study on hemophilia B

CSL Behring announces results of rIX-FP Phase I study on hemophilia B

Gene therapy for bleeding disorder Hemophilia B

Gene therapy for bleeding disorder Hemophilia B

Research examines novel treatment techniques for hemophilia B, VTE

Research examines novel treatment techniques for hemophilia B, VTE

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

Gene therapy and stem cell transplantation successfully reverse hemophilia A

Gene therapy and stem cell transplantation successfully reverse hemophilia A

Thromboelastograph analyzer can help save lives of trauma patients

Thromboelastograph analyzer can help save lives of trauma patients

Massive clotting can destroy placenta and cause miscarriages

Massive clotting can destroy placenta and cause miscarriages

Baxter commences BAX 111 Phase III trial in von Willebrand disease

Baxter commences BAX 111 Phase III trial in von Willebrand disease

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

New book on hemophilia, unintended consequences of medical progress

New book on hemophilia, unintended consequences of medical progress

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

New preclinical data from Baxter's BAX 499 hemophilia study presented at ISTH

Researchers identify elusive gene responsible for Grey Platelet Syndrome

Researchers identify elusive gene responsible for Grey Platelet Syndrome